CN Stock MarketDetailed Quotes

002932 Wuhan Easy Diagnosis Biomedicine

Watchlist
  • 20.12
  • +0.19+0.95%
Not Open Dec 12 15:00 CST
4.68BMarket Cap447.11P/E (TTM)

Wuhan Easy Diagnosis Biomedicine Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-79.10%494.49M
-64.28%778.45M
-69.16%985.87M
-60.26%1.02B
80.12%2.37B
61.96%2.18B
118.16%3.2B
114.73%2.56B
96.94%1.31B
56.37%1.35B
Transactional financial assets
-2.73%63.23M
14.96%63.23M
-88.36%122.59M
-93.72%122.59M
-96.22%65M
-95.22%55M
50.39%1.05B
178.97%1.95B
265.96%1.72B
576.47%1.15B
Notes receivable and accounts receivable
-43.91%902.01M
-54.62%990.73M
-56.90%1.06B
-54.66%1.21B
-45.80%1.61B
-14.70%2.18B
35.07%2.47B
261.23%2.67B
392.89%2.97B
453.14%2.56B
-Notes receivable
--0
-97.24%572.86K
-98.79%572.86K
-99.19%891.42K
-20.38%43.66M
334.25%20.73M
60,261.06%47.4M
44,063.02%109.93M
--54.84M
--4.77M
-Accounts receivable
-42.35%902.01M
-54.21%990.16M
-56.08%1.06B
-52.75%1.21B
-46.28%1.56B
-15.35%2.16B
32.48%2.42B
246.47%2.56B
383.78%2.91B
452.11%2.55B
Other receivables (including interest and dividends)
-89.45%9.38M
-45.98%10.27M
-81.87%10.19M
-36.46%9.33M
252.00%88.93M
8.01%19.01M
211.87%56.18M
34.55%14.69M
65.49%25.26M
51.83%17.6M
-Dividend receivable
--0
----
----
--0
----
----
----
--0
----
----
-Accrued interest receivable
--0
----
----
--0
----
----
----
--0
----
----
-Other receivable
--9.38M
-45.98%10.27M
----
-36.46%9.33M
----
8.01%19.01M
----
34.55%14.69M
----
51.83%17.6M
Contractual assets
--0
----
----
--0
----
----
----
----
----
----
Advance payment
19.96%80.9M
29.88%85.75M
-30.34%50.38M
-19.65%45.49M
-80.17%67.44M
-72.21%66.02M
-79.30%72.32M
-22.42%56.62M
377.00%340.05M
385.72%237.55M
Inventories
14.99%120.51M
-0.26%123.5M
-44.41%125.43M
-50.17%128.77M
-77.54%104.8M
-79.41%123.83M
-46.82%225.62M
-9.19%258.44M
133.12%466.55M
202.39%601.51M
Receivable financing
--0
----
----
-34.99%43.54M
5,806.22%48.58M
-39.59%10M
8,689.43%77.26M
4,629.40%66.97M
74.87%822.57K
3,419.73%16.56M
Assets held for sale
--0
----
----
--0
----
----
----
----
----
----
Non-current assets due within one year
--320.51M
--204.99M
----
--0
----
----
----
--70M
----
----
Other current assets
-28.20%129.85M
-40.56%127.14M
-14.58%172.35M
367.24%174.28M
15,377.02%180.86M
926.69%213.91M
9,236.74%201.76M
3,437.07%37.3M
37.60%1.17M
315.67%20.83M
Total current assets
-53.18%2.12B
-50.85%2.38B
-65.57%2.53B
-64.20%2.75B
-33.72%4.53B
-18.47%4.85B
53.53%7.35B
156.05%7.68B
237.17%6.83B
238.38%5.95B
Non Current assets
Debt investment
--0
----
----
--0
----
----
----
----
----
----
Other debt investment
--0
----
----
--0
----
----
----
----
----
----
Other equity investment
-93.77%10M
-85.71%10M
-72.53%10M
-72.53%10M
507.95%160.5M
733.33%70M
333.33%36.4M
333.33%36.4M
214.29%26.4M
0.00%8.4M
Other non-current financial assets
--0
----
----
--0
----
----
----
----
----
----
Investment real estate
--0
----
----
--0
----
----
----
----
----
----
Long-term equity investment
201.59%145.46M
201.59%145.46M
209.17%151.01M
210.79%146.36M
-10.58%48.23M
-7.08%48.23M
-6.47%48.84M
-9.82%47.09M
53.90%53.94M
48.10%51.9M
Long term receivable account
--0
----
----
--0
----
----
----
----
----
----
Fixed assets
----
-21.14%309.8M
----
----
----
119.72%392.83M
----
136.59%367.29M
----
49.44%178.79M
Constru in process
----
97.03%280.2M
----
----
----
32.04%142.21M
----
65.15%121.52M
----
130.26%107.71M
Productive biological assets
--0
----
----
--0
----
----
----
----
----
----
Oil and gas assets
--0
----
----
--0
----
----
----
----
----
----
Intangible assets
-5.43%16.94M
-1.21%17.15M
2.87%17.37M
4.96%17.7M
6.68%17.91M
5.46%17.36M
1.61%16.88M
1.61%16.86M
0.20%16.79M
-2.42%16.46M
Development expenditure
--0
----
----
--0
----
----
----
----
----
----
Goodwill
--0
----
----
--0
----
----
----
----
----
----
Long deferred expense
-43.13%12.91M
-35.14%12.75M
-13.98%13.78M
-13.60%14.87M
98.49%22.7M
115.37%19.65M
72.66%16.02M
1,089.26%17.21M
598.29%11.44M
397.90%9.12M
Deferred tax assets
28.56%204.33M
25.71%209.43M
22.05%210.36M
20.83%210.18M
440.78%158.93M
508.74%166.61M
667.49%172.35M
946.06%173.95M
62.32%29.39M
101.87%27.37M
Usufruct assets
-14.34%21.9M
-25.23%22.4M
-31.84%23.2M
-37.09%23.38M
64.74%25.57M
101.78%29.96M
146.30%34.03M
153.66%37.16M
--15.52M
--14.85M
Other non current assets
61.89%3.55B
58.23%3.54B
445.00%3.72B
431.26%3.69B
2,020.53%2.19B
1,839.91%2.24B
491.84%682.72M
788.69%695.33M
--103.48M
--115.4M
Total non current assets
48.12%4.71B
45.56%4.55B
210.41%4.71B
206.49%4.64B
390.40%3.18B
489.72%3.13B
211.67%1.52B
262.77%1.51B
142.40%648.31M
118.90%529.99M
Total assets
-11.41%6.83B
-13.07%6.93B
-18.37%7.24B
-19.66%7.39B
3.03%7.71B
23.10%7.98B
68.12%8.87B
169.08%9.19B
226.12%7.48B
223.91%6.48B
Liabilities
Current liabilities
Short term loan
-97.83%3M
-98.42%3M
-98.33%3M
-85.66%23.61M
491.63%138.55M
711.40%190.01M
236.99%180.01M
448.89%164.67M
-21.94%23.42M
--23.42M
Transactional financial liabilities
--0
----
----
--0
----
----
----
----
----
----
Notes payable and accounts payable
-45.98%409.44M
-47.49%493.31M
-50.86%599.09M
-47.32%681.58M
6.82%757.97M
72.98%939.51M
244.81%1.22B
642.28%1.29B
391.13%709.59M
353.56%543.14M
-Notes payable
-91.35%20.74M
-84.04%20.74M
----
--0
104.82%239.8M
140.53%130M
----
----
--117.08M
--54.05M
-Accounts payable
-24.99%388.69M
-41.62%472.57M
-50.86%599.09M
-47.32%681.58M
-12.55%518.17M
65.51%809.51M
244.81%1.22B
642.28%1.29B
310.10%592.52M
308.43%489.1M
Contract liabilities
-35.21%40.59M
-62.96%43.46M
-71.44%40.03M
-82.83%53.17M
-32.76%62.65M
102.05%117.35M
114.06%140.18M
334.95%309.58M
170.26%93.17M
94.91%58.08M
Advance receipts
--0
----
----
--0
----
----
----
----
--4.12M
----
Salaries payable
-57.19%106.12M
-57.21%107.95M
-59.90%118.84M
-56.42%153.72M
905.15%247.92M
765.97%252.27M
591.82%296.35M
448.10%352.7M
63.49%24.66M
46.22%29.13M
Taxs payable
14.21%10.63M
-9.54%13.36M
-55.82%10.03M
-87.79%20.17M
-94.68%9.31M
-94.95%14.77M
-93.16%22.69M
6.61%165.14M
108.11%175.17M
1,038.54%292.61M
Other payable (including interest and dividends)
80.39%65.48M
93.24%59.64M
11.00%75.01M
62.94%75.55M
-50.85%36.3M
-64.29%30.86M
-23.47%67.58M
4.95%46.37M
29.76%73.85M
63.95%86.41M
-Interest payable
--0
----
----
--0
----
----
----
--0
----
----
-Dividend payable
--0
----
----
--0
----
----
----
--0
----
----
-Other payable
--65.48M
93.24%59.64M
----
62.94%75.55M
----
-64.29%30.86M
----
4.95%46.37M
----
63.95%86.41M
Hold and for sell liabilities
--0
----
----
--0
----
----
----
----
----
----
Non current liabilities due within one year
3,002.38%8.16M
-41.59%8.16M
-38.34%8.16M
-59.89%7.29M
-91.53%262.89K
286.85%13.96M
326.10%13.23M
402.39%18.17M
--3.1M
--3.61M
Other current liabilities
-28.50%1.76M
-86.99%1.98M
-31.56%4.03M
-70.43%4.28M
-40.35%2.46M
471.80%15.23M
46.00%5.89M
319.89%14.46M
146.14%4.13M
69.35%2.66M
Total current liabilities
-48.61%645.17M
-53.57%730.86M
-55.88%858.19M
-56.90%1.02B
12.98%1.26B
51.48%1.57B
106.40%1.95B
333.15%2.36B
202.94%1.11B
316.54%1.04B
Current liabilities
Long term loan
--0
----
----
--0
----
----
----
----
----
----
Bonds payable
--0
----
----
--0
----
----
----
----
----
----
Preferred stock
--0
----
----
--0
----
----
----
----
----
----
Perpetual Debt
--0
----
----
--0
----
----
----
----
----
----
Long term salaries pay
--0
----
----
--0
----
----
----
----
----
----
Estimate liabilities
--3.85M
--3.03M
--3.03M
--3.03M
----
----
----
----
----
----
Deferred tax liabilities
44.38%39.65M
44.38%39.65M
44.38%39.65M
27.41%39.59M
534.01%27.46M
534.01%27.46M
534.01%27.46M
617.41%31.07M
43.62%4.33M
43.62%4.33M
Long term deferred income
139.26%14.26M
139.26%14.26M
139.26%14.26M
139.26%14.26M
0.00%5.96M
0.00%5.96M
0.00%5.96M
-0.06%5.96M
84,896.42%5.96M
55,548.87%5.96M
Lease liabilities
-44.90%16.69M
-19.36%16.97M
-31.38%17.81M
-12.04%18.25M
121.40%30.3M
70.97%21.04M
126.06%25.95M
93.24%20.75M
--13.68M
--12.31M
Other non current liabilities
--0
----
----
--0
----
----
----
----
----
----
Total non current liabilities
16.84%74.45M
35.71%73.91M
25.90%74.75M
30.03%75.14M
165.76%63.72M
141.00%54.46M
172.71%59.37M
174.72%57.78M
693.16%23.97M
646.72%22.6M
Total liabilities
-45.45%719.62M
-50.58%804.77M
-53.46%932.94M
-54.82%1.09B
16.20%1.32B
53.39%1.63B
107.90%2B
327.28%2.42B
206.95%1.14B
320.50%1.06B
Shareholders equity
Paid-in capital
0.00%232.52M
0.00%232.52M
48.87%232.52M
48.87%232.52M
48.87%232.52M
48.87%232.52M
48.93%156.19M
48.93%156.19M
61.66%156.19M
126.35%156.19M
Other equity instruments
--0
----
----
--0
----
----
----
----
----
----
-Equity of prefer stock
--0
----
----
--0
----
----
----
----
----
----
-Equity of Perpetual debt
--0
----
----
--0
----
----
----
----
----
----
Capital reserve funds
-0.31%817.89M
-0.03%817.89M
-8.01%820.18M
-7.63%820.18M
-6.37%820.42M
-5.78%818.13M
-2.27%891.56M
-1.84%887.89M
102.33%876.22M
97.99%868.3M
Surplus reserve funds
1.26%615.05M
1.26%615.05M
1.26%615.05M
1.26%615.05M
190.47%607.38M
190.47%607.38M
190.47%607.38M
190.47%607.38M
187.78%209.1M
187.78%209.1M
Retained profit
-0.70%4.41B
-0.17%4.4B
-11.31%4.39B
-10.41%4.36B
-9.34%4.44B
8.75%4.4B
65.35%4.95B
203.44%4.86B
267.39%4.89B
240.59%4.05B
Less:Treasury stock
1,094.63%182.11M
968.45%162.87M
-37.92%9.94M
--0
-53.48%15.24M
-53.48%15.24M
-51.12%16.02M
-51.12%16.02M
-36.71%32.77M
-33.65%32.77M
Other composite income
--0
----
----
--0
----
----
----
----
----
----
Ordinary risk reserve funds
--0
----
----
--0
----
----
----
----
----
----
Specific reserves
--0
----
----
--0
----
----
----
----
----
----
Shareholders equity without minority interests
-3.17%5.89B
-2.44%5.9B
-8.21%6.05B
-7.29%6.03B
-0.33%6.08B
15.17%6.05B
57.36%6.59B
133.07%6.5B
224.14%6.1B
205.28%5.25B
Minority interests
-28.28%221.87M
-23.65%230.06M
-5.97%262.4M
-2.10%266.21M
25.52%309.38M
79.77%301.32M
121.14%279.05M
343.96%271.92M
481.13%246.48M
496.11%167.61M
Total shareholder equity
-4.38%6.11B
-3.45%6.13B
-8.12%6.31B
-7.09%6.29B
0.67%6.39B
17.17%6.35B
59.23%6.87B
137.61%6.77B
229.81%6.35B
209.96%5.42B
Total liabilityies and equity
-11.41%6.83B
-13.07%6.93B
-18.37%7.24B
-19.66%7.39B
3.03%7.71B
23.10%7.98B
68.12%8.87B
169.08%9.19B
226.12%7.48B
223.91%6.48B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -79.10%494.49M-64.28%778.45M-69.16%985.87M-60.26%1.02B80.12%2.37B61.96%2.18B118.16%3.2B114.73%2.56B96.94%1.31B56.37%1.35B
Transactional financial assets -2.73%63.23M14.96%63.23M-88.36%122.59M-93.72%122.59M-96.22%65M-95.22%55M50.39%1.05B178.97%1.95B265.96%1.72B576.47%1.15B
Notes receivable and accounts receivable -43.91%902.01M-54.62%990.73M-56.90%1.06B-54.66%1.21B-45.80%1.61B-14.70%2.18B35.07%2.47B261.23%2.67B392.89%2.97B453.14%2.56B
-Notes receivable --0-97.24%572.86K-98.79%572.86K-99.19%891.42K-20.38%43.66M334.25%20.73M60,261.06%47.4M44,063.02%109.93M--54.84M--4.77M
-Accounts receivable -42.35%902.01M-54.21%990.16M-56.08%1.06B-52.75%1.21B-46.28%1.56B-15.35%2.16B32.48%2.42B246.47%2.56B383.78%2.91B452.11%2.55B
Other receivables (including interest and dividends) -89.45%9.38M-45.98%10.27M-81.87%10.19M-36.46%9.33M252.00%88.93M8.01%19.01M211.87%56.18M34.55%14.69M65.49%25.26M51.83%17.6M
-Dividend receivable --0----------0--------------0--------
-Accrued interest receivable --0----------0--------------0--------
-Other receivable --9.38M-45.98%10.27M-----36.46%9.33M----8.01%19.01M----34.55%14.69M----51.83%17.6M
Contractual assets --0----------0------------------------
Advance payment 19.96%80.9M29.88%85.75M-30.34%50.38M-19.65%45.49M-80.17%67.44M-72.21%66.02M-79.30%72.32M-22.42%56.62M377.00%340.05M385.72%237.55M
Inventories 14.99%120.51M-0.26%123.5M-44.41%125.43M-50.17%128.77M-77.54%104.8M-79.41%123.83M-46.82%225.62M-9.19%258.44M133.12%466.55M202.39%601.51M
Receivable financing --0---------34.99%43.54M5,806.22%48.58M-39.59%10M8,689.43%77.26M4,629.40%66.97M74.87%822.57K3,419.73%16.56M
Assets held for sale --0----------0------------------------
Non-current assets due within one year --320.51M--204.99M------0--------------70M--------
Other current assets -28.20%129.85M-40.56%127.14M-14.58%172.35M367.24%174.28M15,377.02%180.86M926.69%213.91M9,236.74%201.76M3,437.07%37.3M37.60%1.17M315.67%20.83M
Total current assets -53.18%2.12B-50.85%2.38B-65.57%2.53B-64.20%2.75B-33.72%4.53B-18.47%4.85B53.53%7.35B156.05%7.68B237.17%6.83B238.38%5.95B
Non Current assets
Debt investment --0----------0------------------------
Other debt investment --0----------0------------------------
Other equity investment -93.77%10M-85.71%10M-72.53%10M-72.53%10M507.95%160.5M733.33%70M333.33%36.4M333.33%36.4M214.29%26.4M0.00%8.4M
Other non-current financial assets --0----------0------------------------
Investment real estate --0----------0------------------------
Long-term equity investment 201.59%145.46M201.59%145.46M209.17%151.01M210.79%146.36M-10.58%48.23M-7.08%48.23M-6.47%48.84M-9.82%47.09M53.90%53.94M48.10%51.9M
Long term receivable account --0----------0------------------------
Fixed assets -----21.14%309.8M------------119.72%392.83M----136.59%367.29M----49.44%178.79M
Constru in process ----97.03%280.2M------------32.04%142.21M----65.15%121.52M----130.26%107.71M
Productive biological assets --0----------0------------------------
Oil and gas assets --0----------0------------------------
Intangible assets -5.43%16.94M-1.21%17.15M2.87%17.37M4.96%17.7M6.68%17.91M5.46%17.36M1.61%16.88M1.61%16.86M0.20%16.79M-2.42%16.46M
Development expenditure --0----------0------------------------
Goodwill --0----------0------------------------
Long deferred expense -43.13%12.91M-35.14%12.75M-13.98%13.78M-13.60%14.87M98.49%22.7M115.37%19.65M72.66%16.02M1,089.26%17.21M598.29%11.44M397.90%9.12M
Deferred tax assets 28.56%204.33M25.71%209.43M22.05%210.36M20.83%210.18M440.78%158.93M508.74%166.61M667.49%172.35M946.06%173.95M62.32%29.39M101.87%27.37M
Usufruct assets -14.34%21.9M-25.23%22.4M-31.84%23.2M-37.09%23.38M64.74%25.57M101.78%29.96M146.30%34.03M153.66%37.16M--15.52M--14.85M
Other non current assets 61.89%3.55B58.23%3.54B445.00%3.72B431.26%3.69B2,020.53%2.19B1,839.91%2.24B491.84%682.72M788.69%695.33M--103.48M--115.4M
Total non current assets 48.12%4.71B45.56%4.55B210.41%4.71B206.49%4.64B390.40%3.18B489.72%3.13B211.67%1.52B262.77%1.51B142.40%648.31M118.90%529.99M
Total assets -11.41%6.83B-13.07%6.93B-18.37%7.24B-19.66%7.39B3.03%7.71B23.10%7.98B68.12%8.87B169.08%9.19B226.12%7.48B223.91%6.48B
Liabilities
Current liabilities
Short term loan -97.83%3M-98.42%3M-98.33%3M-85.66%23.61M491.63%138.55M711.40%190.01M236.99%180.01M448.89%164.67M-21.94%23.42M--23.42M
Transactional financial liabilities --0----------0------------------------
Notes payable and accounts payable -45.98%409.44M-47.49%493.31M-50.86%599.09M-47.32%681.58M6.82%757.97M72.98%939.51M244.81%1.22B642.28%1.29B391.13%709.59M353.56%543.14M
-Notes payable -91.35%20.74M-84.04%20.74M------0104.82%239.8M140.53%130M----------117.08M--54.05M
-Accounts payable -24.99%388.69M-41.62%472.57M-50.86%599.09M-47.32%681.58M-12.55%518.17M65.51%809.51M244.81%1.22B642.28%1.29B310.10%592.52M308.43%489.1M
Contract liabilities -35.21%40.59M-62.96%43.46M-71.44%40.03M-82.83%53.17M-32.76%62.65M102.05%117.35M114.06%140.18M334.95%309.58M170.26%93.17M94.91%58.08M
Advance receipts --0----------0------------------4.12M----
Salaries payable -57.19%106.12M-57.21%107.95M-59.90%118.84M-56.42%153.72M905.15%247.92M765.97%252.27M591.82%296.35M448.10%352.7M63.49%24.66M46.22%29.13M
Taxs payable 14.21%10.63M-9.54%13.36M-55.82%10.03M-87.79%20.17M-94.68%9.31M-94.95%14.77M-93.16%22.69M6.61%165.14M108.11%175.17M1,038.54%292.61M
Other payable (including interest and dividends) 80.39%65.48M93.24%59.64M11.00%75.01M62.94%75.55M-50.85%36.3M-64.29%30.86M-23.47%67.58M4.95%46.37M29.76%73.85M63.95%86.41M
-Interest payable --0----------0--------------0--------
-Dividend payable --0----------0--------------0--------
-Other payable --65.48M93.24%59.64M----62.94%75.55M-----64.29%30.86M----4.95%46.37M----63.95%86.41M
Hold and for sell liabilities --0----------0------------------------
Non current liabilities due within one year 3,002.38%8.16M-41.59%8.16M-38.34%8.16M-59.89%7.29M-91.53%262.89K286.85%13.96M326.10%13.23M402.39%18.17M--3.1M--3.61M
Other current liabilities -28.50%1.76M-86.99%1.98M-31.56%4.03M-70.43%4.28M-40.35%2.46M471.80%15.23M46.00%5.89M319.89%14.46M146.14%4.13M69.35%2.66M
Total current liabilities -48.61%645.17M-53.57%730.86M-55.88%858.19M-56.90%1.02B12.98%1.26B51.48%1.57B106.40%1.95B333.15%2.36B202.94%1.11B316.54%1.04B
Current liabilities
Long term loan --0----------0------------------------
Bonds payable --0----------0------------------------
Preferred stock --0----------0------------------------
Perpetual Debt --0----------0------------------------
Long term salaries pay --0----------0------------------------
Estimate liabilities --3.85M--3.03M--3.03M--3.03M------------------------
Deferred tax liabilities 44.38%39.65M44.38%39.65M44.38%39.65M27.41%39.59M534.01%27.46M534.01%27.46M534.01%27.46M617.41%31.07M43.62%4.33M43.62%4.33M
Long term deferred income 139.26%14.26M139.26%14.26M139.26%14.26M139.26%14.26M0.00%5.96M0.00%5.96M0.00%5.96M-0.06%5.96M84,896.42%5.96M55,548.87%5.96M
Lease liabilities -44.90%16.69M-19.36%16.97M-31.38%17.81M-12.04%18.25M121.40%30.3M70.97%21.04M126.06%25.95M93.24%20.75M--13.68M--12.31M
Other non current liabilities --0----------0------------------------
Total non current liabilities 16.84%74.45M35.71%73.91M25.90%74.75M30.03%75.14M165.76%63.72M141.00%54.46M172.71%59.37M174.72%57.78M693.16%23.97M646.72%22.6M
Total liabilities -45.45%719.62M-50.58%804.77M-53.46%932.94M-54.82%1.09B16.20%1.32B53.39%1.63B107.90%2B327.28%2.42B206.95%1.14B320.50%1.06B
Shareholders equity
Paid-in capital 0.00%232.52M0.00%232.52M48.87%232.52M48.87%232.52M48.87%232.52M48.87%232.52M48.93%156.19M48.93%156.19M61.66%156.19M126.35%156.19M
Other equity instruments --0----------0------------------------
-Equity of prefer stock --0----------0------------------------
-Equity of Perpetual debt --0----------0------------------------
Capital reserve funds -0.31%817.89M-0.03%817.89M-8.01%820.18M-7.63%820.18M-6.37%820.42M-5.78%818.13M-2.27%891.56M-1.84%887.89M102.33%876.22M97.99%868.3M
Surplus reserve funds 1.26%615.05M1.26%615.05M1.26%615.05M1.26%615.05M190.47%607.38M190.47%607.38M190.47%607.38M190.47%607.38M187.78%209.1M187.78%209.1M
Retained profit -0.70%4.41B-0.17%4.4B-11.31%4.39B-10.41%4.36B-9.34%4.44B8.75%4.4B65.35%4.95B203.44%4.86B267.39%4.89B240.59%4.05B
Less:Treasury stock 1,094.63%182.11M968.45%162.87M-37.92%9.94M--0-53.48%15.24M-53.48%15.24M-51.12%16.02M-51.12%16.02M-36.71%32.77M-33.65%32.77M
Other composite income --0----------0------------------------
Ordinary risk reserve funds --0----------0------------------------
Specific reserves --0----------0------------------------
Shareholders equity without minority interests -3.17%5.89B-2.44%5.9B-8.21%6.05B-7.29%6.03B-0.33%6.08B15.17%6.05B57.36%6.59B133.07%6.5B224.14%6.1B205.28%5.25B
Minority interests -28.28%221.87M-23.65%230.06M-5.97%262.4M-2.10%266.21M25.52%309.38M79.77%301.32M121.14%279.05M343.96%271.92M481.13%246.48M496.11%167.61M
Total shareholder equity -4.38%6.11B-3.45%6.13B-8.12%6.31B-7.09%6.29B0.67%6.39B17.17%6.35B59.23%6.87B137.61%6.77B229.81%6.35B209.96%5.42B
Total liabilityies and equity -11.41%6.83B-13.07%6.93B-18.37%7.24B-19.66%7.39B3.03%7.71B23.10%7.98B68.12%8.87B169.08%9.19B226.12%7.48B223.91%6.48B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.